Management of Severe Hyperglycemia (Glucose 516 mg/dL)
For a glucose level of 516 mg/dL, immediate insulin administration is required, with point-of-care glucose monitoring every 1-2 hours until glucose levels stabilize below 180 mg/dL, then every 4-6 hours thereafter. 1
Initial Management Algorithm
Immediate intervention required:
- For non-critically ill patients: Administer subcutaneous insulin using a basal-bolus-correction approach
- For critically ill patients: Consider intravenous insulin infusion with monitoring every 30 minutes to 2 hours
Insulin dosing strategy:
- Correction dose: Administer rapid-acting insulin immediately to address severe hyperglycemia
- Basal insulin: Initiate or adjust basal insulin to provide 24-hour background coverage
- Follow-up dose: Schedule next insulin dose based on nutritional status:
- If eating: Before next meal (typically 4-6 hours)
- If NPO or continuous feeding: Every 4-6 hours
Monitoring Protocol
- Initial phase (glucose >250 mg/dL): Check glucose every 1-2 hours
- After stabilization (<180 mg/dL):
- Eating patients: Before meals
- NPO patients: Every 4-6 hours 1
- For IV insulin: Every 30 minutes to 2 hours based on protocol
Treatment Goals
- Target glucose range: 140-180 mg/dL for most hospitalized patients 1
- More stringent targets (110-140 mg/dL) may be appropriate for selected patients if achievable without significant hypoglycemia 1
- Avoid using sliding scale insulin as the sole treatment method 1
Important Considerations
Nutritional status affects dosing frequency:
Hypoglycemia prevention:
- Monitor closely for glucose <70 mg/dL
- Have standardized hypoglycemia treatment protocol in place
- If enteral nutrition is interrupted while on insulin, start 10% dextrose infusion immediately 1
Common Pitfalls to Avoid
Using only sliding scale insulin - This reactive approach is strongly discouraged and associated with poor outcomes 1
Inadequate monitoring frequency - Severe hyperglycemia requires frequent monitoring until stabilized
Failing to adjust for nutritional status - Insulin regimen must match the patient's intake pattern
Overlooking basal insulin needs - Even NPO patients require basal insulin coverage, especially those with type 1 diabetes
Aggressive overcorrection - Rapid normalization of severely elevated glucose can lead to adverse outcomes; aim for gradual improvement toward target range 1
Remember that persistent hyperglycemia >180 mg/dL is associated with increased mortality and morbidity, including infections and longer hospital stays 2, making prompt and appropriate insulin administration essential for improving outcomes.